Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model

Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model

Carboxy-dehydroevodiamine·HCl (cx-DHED) is a derivative of DHED, which improves memory impairment. Carboxyl modification increases solubility in water, indicating that its bioavailability is higher than that of DHED. Cx-DHED is expected to have better therapeutic effects on Alzheimer's disease...

Full description

Bibliographic Details
Main Authors:	Shinwoo Kang, Sungji Ha, Hyunjun Park, Eunjoo Nam, Won Hyuk Suh, Yoo-Hun Suh, Keun-A Chang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-11-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	Alzheimer's disease carboxy-dehydroevodiamine memory impairment 5xFAD synaptic destabilization
Online Access:	https://www.frontiersin.org/article/10.3389/fnbeh.2018.00273/full

Similar Items

Effects of a dehydroevodiamine-derivative on synaptic destabilization and memory impairment in the 5xFAD, Alzheimer's disease mouse model
by: Chang, K.-A, et al.
Published: (2018)

The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer’s Disease
by: Hyunjun Park, et al.
Published: (2019-01-01)

Region-specific amyloid-β accumulation in the olfactory system influences olfactory sensory neuronal dysfunction in 5xFAD mice
by: Gowoon Son, et al.
Published: (2021-01-01)

Long-Term Treatment of Cuban Policosanol Attenuates Abnormal Oxidative Stress and Inflammatory Response via Amyloid Plaques Reduction in 5xFAD Mice
by: Jin-Ho Kim, et al.
Published: (2021-08-01)

Untersuchungen über die Auswirkungen von Geschlecht und genetischem Hintergrund auf die Alzheimerpathologie im 5xFAD-Mausmodell
by: Nordmeyer, Philipp Johannes
Published: (2015)

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer’s Disease Pathology in 5xFAD Model Mice
by: Malena dos Santos Guilherme, et al.
Published: (2020-08-01)

Selective Regional Loss of Cortical Synapses Lacking Presynaptic Mitochondria in the 5xFAD Mouse Model
by: Na-young Seo, et al.
Published: (2021-06-01)

Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
by: Yoichiro Abe, et al.
Published: (2020-05-01)

The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
by: Seong Gak Jeon, et al.
Published: (2020-09-01)

Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice
by: Apostolia Fragkouli, et al.
Published: (2014-10-01)

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
by: Johanna Michael, et al.
Published: (2021-03-01)

Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
by: Guofang Shen, et al.
Published: (2020-08-01)

Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer’s Disease
by: Irina Belaya, et al.
Published: (2021-08-01)

Cyclopentanone Derivative Attenuates Memory Impairment by Inhibiting Amyloid Plaques Formation in the 5xFAD Mice
by: Rahim Ullah, et al.
Published: (2021-09-01)

Attenuation of Spatial Memory in 5xFAD Mice by Halting Cholinesterases, Oxidative Stress and Neuroinflammation Using a Cyclopentanone Derivative
by: Rahim Ullah, et al.
Published: (2020-10-01)

Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
by: Youmans Katherine L, et al.
Published: (2012-03-01)

Bazhu Decoction, a Traditional Chinese Medical Formula, Ameliorates Cognitive Deficits in the 5xFAD Mouse Model of Alzheimer’s Disease
by: Axiang Peng, et al.
Published: (2019-11-01)

A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
by: Antonio J. López-Gambero, et al.
Published: (2021-05-01)

Voluntary Wheel Running Did Not Alter Gene Expression in 5xfad Mice, but in Wild-Type Animals Exclusively after One-Day of Physical Activity
by: Anna Wierczeiko, et al.
Published: (2021-03-01)

Cerebrovascular pathology during the progression of experimental Alzheimer's disease
by: Patrizia Giannoni, et al.
Published: (2016-04-01)

Intérêt de stratégie multi-cibles (cholinergique et sérotoninergique) pour le traitement de la maladie d'Alzheimer : étude in vivo et ex vivo dans différents modèles murins
by: Hamidouche, Katia
Published: (2018)

Idebenone Decreases Aβ Pathology by Modulating RAGE/Caspase-3 Signaling and the Aβ Degradation Enzyme NEP in a Mouse Model of AD
by: Hyun-ju Lee, et al.
Published: (2021-09-01)

Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice
by: Neta Lax, et al.
Published: (2020-02-01)

Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer’s Disease
by: Rotem Volkman, et al.
Published: (2019-09-01)

Amyloid Beta-Mediated Changes in Synaptic Function and Spine Number of Neocortical Neurons Depend on NMDA Receptors
by: Michaela K. Back, et al.
Published: (2021-06-01)

Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer’s disease
by: Irina Belaya, et al.
Published: (2020-09-01)

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
by: Dina Medina-Vera, et al.
Published: (2020-11-01)

Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer’s disease-like pathology
by: Kathrin Gnoth, et al.
Published: (2020-11-01)

Intracranial alternating current stimulation facilitates neurogenesis in a mouse model of Alzheimer’s disease
by: Qian Liu, et al.
Published: (2020-07-01)

Assessing Olfactory Learning and Memory in the 5XFAD Mouse Model of Alzheimer’s Disease
by: Roddick, Kyle
Published: (2012)

Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice
by: Soo Jung Shin, et al.
Published: (2018-12-01)

Disruption of the astrocyte–neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer’s disease animal model
by: Moonseok Choi, et al.
Published: (2021-07-01)

Investigation of FADS Gene Cluster Single Nucleotide Polymorphisms in End-Stage Renal Disease Compared With Normal Controls
by: Amirhossein Miladipour, et al.
Published: (2021-09-01)

4-Hydroxynonenal Immunoreactivity Is Increased in the Frontal Cortex of 5XFAD Transgenic Mice
by: Sang-Wook Shin, et al.
Published: (2020-09-01)

Impact of Acute and Chronic Amyloid-β Peptide Exposure on Gut Microbial Commensals in the Mouse
by: Malena dos Santos Guilherme, et al.
Published: (2020-05-01)

HPLC-based activity profiling for pharmacologically and toxicologically relevant natural products – principles and recent examples
by: Matthias Hamburger
Published: (2019-01-01)

Topographical Visualization of the Reciprocal Projection between the Medial Septum and the Hippocampus in the 5XFAD Mouse Model of Alzheimer’s Disease
by: Sujin Kim, et al.
Published: (2019-08-01)

Fad Fashion : ur ett varumärkesperspektiv
by: LIDÉN, HELEN, et al.
Published: (2010)

Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer's disease
by: Moonseok Choi, et al.
Published: (2020-08-01)

MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer’s Disease
by: Yu-on Jeong, et al.
Published: (2018-06-01)